F2 and Acute hepatitis: Additionally, patient S13 was treated with rosuvastatin (Crestor) at a dose of 20 mg/day, resulting in acute hepatitis symptoms, including elevated levels of liver enzymes (GOT (511.4 U/L), GPT (721.6 U/L), and GGT (339.3 U/L)) along with a decreased prothrombin ratio of 66%.